A Close Look at Cash and Debt Levels for These Big Healthcare Stocks

Wall St. Watchdog reveals information on the cash and debt levels of some of the largest companies, as measured by market capitalization, in the Healthcare sector.

  • Novartis AG (ADR) (NYSE:NVS): This company has $8,134,000,000 in cash against $27,505,000,000 in debt. The shares recently traded at $59.36 and its market capitalization is $162,346,500,000. About the company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  • Pfizer Inc. (NYSE:PFE): This company has $28,479,000,000 in cash against $41,916,000,000 in debt. The shares recently traded at $18.14 and its market capitalization is $143,326,500,000. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • GlaxoSmithKline plc (ADR) (NYSE:GSK): This company has $10,147,332,546 in cash against $26,050,392,290 in debt. The shares recently traded at $43.99 and its market capitalization is $112,935,250,923. About the company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders.
  • AstraZeneca plc (ADR) (NYSE:AZN): This company has $12,550,000,000 in cash against $9,792,000,000 in debt. The shares recently traded at $47.16 and its market capitalization is $64,316,850,000. About the company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
  • Bayer AG (ADR) (OTC:BAYRY): This company has $5,471,134,411 in cash against $15,915,770,542 in debt. The shares recently traded at $74.53 and its market capitalization is $62,601,334,855. About the company: Bayer AG develops, produces, and markets pharmaceuticals and health care products, agricultural products, and specialty materials worldwide.  The Company’s Pharmaceuticals segment provides prescription pharmaceuticals to treat hypertension, cardiovascular and infectious diseases, cancer, multiple sclerosis, and contraception, as well as contrast media for use in diagnostic imaging.
  • Novo Nordisk A/S (ADR) (NYSE:NVO): This company has $3,059,440,119 in cash against $288,198,401 in debt. The shares recently traded at $118.64 and its market capitalization is $56,425,370,041. About the company: Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
  • Amgen, Inc. (NASDAQ:AMGN): This company has $17,422,000,000 in cash against $13,930,000,000 in debt. The shares recently traded at $53.31 and its market capitalization is $49,563,930,000. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Bristol Myers Squibb Co. (NYSE:BMY): This company has $7,301,000,000 in cash against $5,311,000,000 in debt. The shares recently traded at $28.04 and its market capitalization is $47,826,890,000. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Eli Lilly + Co. (NYSE:LLY): This company has $6,727,000,000 in cash against $6,728,800,000 in debt. The shares recently traded at $37.16 and its market capitalization is $43,019,710,000. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA): This company has $1,284,000,000 in cash against $6,441,000,000 in debt. The shares recently traded at $42.06 and its market capitalization is $41,596,460,000. About the company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Medtronic, Inc. (NYSE:MDT): This company has $2,428,000,000 in cash against $9,835,000,000 in debt. The shares recently traded at $33.97 and its market capitalization is $36,040,540,000. About the company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Express Scripts, Inc. (NASDAQ:ESRX): This company has $523,700,000 in cash against $4,088,500,000 in debt. The shares recently traded at $51.65 and its market capitalization is $25,215,790,000. About the company: Express Scripts, Inc is a full service pharmacy benefit management and specialty managed care company serving clients throughout North America. The Company’s customers include managed care organizations, insurance carriers, third party administrators, employers, and union-sponsored benefit plans. Express provides pharmacy network management, formulary management, and other services.
  • Biogen Idec Inc. (NASDAQ:BIIB): This company has $1,207,744,000 in cash against $1,274,111,000 in debt. The shares recently traded at $99.67 and its market capitalization is $24,174,540,000. About the company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Covidien plc (NYSE:COV): This company has $1,565,000,000 in cash against $4,166,000,000 in debt. The shares recently traded at $48.98 and its market capitalization is $24,168,750,000. About the company: Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
  • Allergan, Inc. (NYSE:AGN): This company has $2,740,300,000 in cash against $2,237,100,000 in debt. The shares recently traded at $77.38 and its market capitalization is $23,584,090,000. About the company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>

More from The Cheat Sheet